Final report on the safety assessment of Ascorbyl Palmitate, Ascorbyl Dipalmitate, Ascorbyl Stearate, Erythorbic Acid, and Sodium Erythorbate

International Journal of Toxicology

Volumn 18, Issue SUPPL. 3, 1999, Pages 1-26

  Andersen, F Alan ^a  

^a CIR ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBYL PALMITATE; ASCORBYL STEARATE; COSMETIC; FATTY ACID ESTER; HAIR DYE; ISOASCORBIC ACID; LONG CHAIN FATTY ACID;

ACUTE TOXICITY; BLADDER STONE; CANCER INHIBITION; CHEMICAL REACTION; CONTACT SENSITIZATION; COSMETIC INDUSTRY; GENOTOXICITY; HUMAN; NONHUMAN; PHYSICAL CHEMISTRY; REVIEW; RISK ASSESSMENT; SKIN IRRITATION; SKIN PENETRATION; STEREOISOMERISM; WEIGHT GAIN;

EID: 0033451978     PISSN: 10915818     EISSN: None     Source Type: Journal    
DOI: 10.1177/109158189901800303     Document Type: Review

References (109)

1. Abe, I., S. Saito, K. Hori, M. Suzuki, and H. Sato. 1979. On the dual action of ascorbate and erythorbate on rat liver lysosomes. Sci. Rep. Res. Inst. Tohoku Univ. 26:39-45.
2. Abe, I., S. Saito, K. Hori, M. Suzuki, and H. Sato. 1983. Effect of erythorbate on N-methyl-N′-nitro-N-nitrosoguanidine-inducedstomach carcinogenesis in F344 rats. Sci. Rep. Res. Inst. Tohoku Univ. 30:40-55.
3. Abe, I., S. Saito, K. Hori, M. Suzuki, and H. Sato. 1984. Sodium erythorbate is not carcinogenic in F344 rats. Exp. Mol. Pathol. 41:35-43.
4. Aldrich Chemical Company. 1992. Catalog handbook of fine chemicals, 741. Milwaukee, WI: Aldrich Chemical Company.
5. Anderson, R. L. 1991. Early indicators of bladder carcinogenesis produced by non-genotoxic agents. Mutat. Res. 248:261-270.
6. Anderson, S. M. L., W. H. I. McLean, and R. J. Elliott. 1991. The effects of ascorbic acid on collagen synthesis by cultured human skin fibroblasts. Biochem. Soc. Trans. 19:48S.
7. Arakawa, N., E. Suzuki, T. Kurata, M. Otsuka, and C. Inagaki. 1986. Effect of erythorbic acid administration on ascorbic acid content in guinea pig tissues. J. Nutr. Vitaminol. (Tokyo) 32:171-181.
8. Bird, R. P., and J. C. Alexander. 1981. Effects of vitamin E and ascorbyl palmitate on cultured myocardial cells exposed to oxidized fats. J. Toxicol. Environ. Health 7:59-67.
9. Brewer, R. F., V. J. Carroll, and C. B. Cookston. 1987. Application of sodium erythorbate sprays and dusts for reduction of ozone damage to Thompson seedless grapes in California. Hort. Sci. 22:1153.
10. Budavari, S., ed. 1989. The Merck Index. An encyclopedia of chemicals, drugs, and biologicals, 11th ed., 809. Rahway, NJ: Merck & Co.
11. 2
12. 2
13. Cohen, S. M., M. Cano, E. M. Garland, M. St. John, and L. L. Arnold. 1995. Urinary and urothelial effects of sodium salts in male rats. Carcinogenesis 16:343-348.
14. 2
15. 2
16. Darr, D., S. Combs, S. Dunston, T. Manning, and S. Pinnell. 1992. Topical vitamin C protects porcine skin from ultraviolet radiation-induced damage. Br. J. Dermatol. 127:247-253.
17. Ema, M., T. Itami, and S. Kanoh. 1985. Effect of sodium erythorbate on pregnant rats and their offspring. J. Food Hyg. Soc. Jpn. 26:448-453.
18. 2
19. European Economic Community (EEC). 1994. EEC cosmetics directive, as amended, annexes I through VII. Brussels: EEC. 76/768/EEC.
20. Federation of American Societies for Experimental Biology (FASEB). 1979. Evaluation of the health aspects of Ascorbic Acid, Sodium Ascorbate, Calcium Ascorbate, Erythorbic Acid, Sodium Erythorbate, and Ascorbyl Palmitate as food ingredients. Prepared under contract for FDA. NTIS PB80-128796. (48 pages.)
21. Fitzhugh, O. G., and A. A. Nelson. 1946. Subacute and chronic toxicities of ascorbyl palmitate. Proc. Soc. Exp. Biol. Med. 80:361-362.
22. Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO). 1996. Summary of evaluations performed by the Joint FAO/WHO Expert Committee on Food Additives (JECFA), A-26. USA: International Life Sciences Institute. Rome, Italy.
23. Food and Drug Administration (FDA). 1983. Ascorbic acid and its sodium and calcium salts, erythorbic acid and its sodium salt, and ascorbyl palmitate; proposed affirmation of GRAS status and removal of calcium ascorbate from the list of GRAS ingredients. Fed Register 48:1735-1739.
24. FDA. 1984. Frequency of use of cosmetic ingredients. FDA Database. Washington, DC: FDA.
25. FDA. 1992. Modification in voluntary filing of cosmetic product ingredient and cosmetic raw material composition statements. Fed. Register 57:3128-3130.
26. 2
27. FDA. 1996. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: author.
28. Food and Drug Research Laboratories, Inc. 1974. Teratologic evaluation of FDA 71-68, Sodium Erythorbate in mice and rats. Prepared for the FDA. NTIS No. PB-245 531.
29. Fukushima, S., Y. Kurata, M. A. Shibata, E. Ikawa, and N. Ito. 1984. Promotion by ascorbic acid, sodium erythorbate and ethoxyquin of neoplastic lesions in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Cancer Lett. 23:29-37.
30. Fukushima, S., T. Ogiso, Y. Kurata, M. Shibata, and T. Kakizoe. 1987a. Absence of promotion potential for calcium L-ascorbate, L-ascorbic dipalmitate, L-ascorbic stearate and erythorbic acid on rat urinary bladder carcinogenesis. Cancer Lett. 35:17-25.
31. Fukushima, S., T. Sakata, Y. Tagawa, M. A. Shibata, M. Hirose, and N. Ito. 1987b. Different modifying response of butylated hydroxy anisole, butylated hydroxytoluene, and other antioxidants in N,N-dibutylnitrosamine esophagus and forestomach carcinogenesis of rats. Cancer Res. 47:2113-2116.
32. Fukushima, S., M. A. Shibata, Y. Kurata, S. Tamano, and T. Masui. 1986. Changes in the urine and scanning electron microscopically observed appearance of the rat bladder following treatment with tumor promoters. Jpn. J. Cancer Res. 77:1074-1082.
33. Gennaro, A. R., ed. 1990. Remington's pharmaceutical sciences. 18th ed., 1286. Easton, PA: Mack Publishing Co.
34. Grant, J., ed. 1972. Hackh's chemical dictionary, 4th ed., 247. New York: McGraw-Hill.
35. Hara, A., M. Shinoda, T. Kanuzu, T. Nakayama, Y. Deyashiki, and H. Sawada. 1991. Inhibition of dimeric dihydriol dehydrogenases of rabbit and pig lens by ascorbic acid. Biochem. J. 275:121-126.
36. Hazardous Substances Data Bank (HSDB). 1994. HSDB database. Bethesda: National Library of Medicine.
37. Hornig, D. 1977. Interaction of erythorbic acid with ascorbic acid catabolism. Acta Vitaminol Enzymol. 31:9-14.
38. Huang, M. T., E. E. Deschner, H. L. Newmark, et al. 1992. Effect of dietary curcumin and ascorbyl palmitate on azoxymethanol-induced colonic epithelial cell proliferation and focal areas of dysplasia. Cancer Lett. 64:117-121.
39. Hughes, R. E., and R. J. Hurley. 1969. The uptake of D-araboascorbic acid (D-isoascorbic acid) by guinea pig tissues. Br. J. Nutr. 23:211-216.
40. Inagaki, C., and K. Kawaguchi. 1966. The metabolism of fatty acid esters of L-ascorbic acid. Excretion and accumulation of ascorbic acid dipalmitates after administration of ascorbic acid mono- and dipalmitates of ascorbic acid. Vitamins 34:293-297.
41. Inagaki, C., N. Arakawa, and Y. Atsumi. 1968. Studies on the metabolism of fatty acid esters of L-ascorbic acid. II. Hydrolysis of 6-O-palmitoyl-and 2,6-O-dipalmitoyl-ascorbic acids. Vitamins 37:147-151.
42. Inai, K., H. Akamizu, R. Eto, et al. 1989. Tumorigenicity study of sodium erythorbate administered orally to mice. H. I. J. M. 38:135-139.
43. 2
44. Ishidate, M. Jr., M. Hayashi, M. Sawada, et al. 1971. Cytotoxicity test on medical drugs - chromosomal aberration tests with Chinese hamster cells in vitro. Eisei Shikenjo Hokoku 96:55-61.
45. Ishidate, M. Jr., T. Sufuni, and T. Nohmi. 1990. Quantitative evaluation on the genotoxic potency of chemicals, 83-92. Division of Genetics and Mutagenesis, National Institute of Hygienic Sciences. Submitted by the Center for Food Safety and Applied Nutrition: FOI request dated 4-17-95.
46. Ishidate, M. Jr., T. Sofuni, and K. Yoshikawa, et al. 1984. Primary mutagenicity screening of food additives currently used in Japan. Food Chem. Toxic. 22:623-636.
47. Ito, N., and S. Fukushima. 1989. Promotion of urinary bladder carcinogenesis in experimental animals. Exp. Pathol. 36:1-15.
48. Ito, N., N. Hirose, S. Fukushima, H. Tsuda, T. Shirai, and M. Tatematsu. 1986. Studies on antioxidants: Their carcinogenic and modifying effects on chemical carcinogenesis. Fd. Chem. Toxicol. 24:1071-1082.
49. Ito, N., H. Tsuda, M. Tatematsu, et al. 1988. Enhancing effects of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats - an approach for a new medium-term bioassay system. Carcinogenesis 9:387-394.
50. 2
51. Joint Expert Committee on Food Additives (JECFA). 1974. Isoascorbic Acid entry. Technical Report Series 539, 19. Submitted by FDA in response to an FOI request dated 4/17/95.
52. Jonker, D., V. S. Lee, R. J. Hargreaves, and B. G. Lake. 1988. Comparison of the effects of ascorbyl palmitate and L-ascorbic acid on paracetamol-induced hepatotoxicity in the mouse. Toxicology 52:287-295.
53. Jorgenson, T. A., C. J. Rushbrook, G. W. Newell, and S. Green. 1978a. Study of the mutagenic potential of three GRAS chemicals in mice by the heritable translocation test. Mutat. Res. 53:125.
54. Jorgenson, T. A., C. J. Rushbrook, G. W. Newell, and S. Green. 1978b. In vivo mutagenesis investigations of four GRAS chemicals. Mutat. Res. 53: 205.
55. Kawachi, T., T. Komatsu, T. Kada, et al. 1980. Results of recent studies on the relevance of various short-term screening tests in Japan. Appl. Methods. Oncol. 3:253-267.
56. Kawanishi, T., Y. Ohno, A. Takahashi, et al. 1981a. Studies on nitrosamine formation by the interaction between drugs and nitrite. I. Measurement of the amount of nitrosamine formed in rat and guinea pig stomachs. J. Toxicol. Sci. 6:261-270.
57. Kawanishi, T., Y. Ohno, A. Takahashi, et al. 1981b. Studies on nitrosamine formation by the interaction between drugs and nitrite. II. Hepatoxicity by the simultaneous administration of several drugs and nitrite. J. Toxicol. Sci. 6:271-286.
58. Koroleva, L. V., L. P. Rzaeva, A. G. Strenkovskaya, and L. G. Bocharova. 1981. Penetration of some vitamin preparations through the skin barrier. In Gisto-Gematicheskie Bar'ery Neirogumoral'n Regul, 114-117.
59. Kurata, Y., R. Hasegawa, T. Inoue, M. Asamoto, and S. Fukushima. 1986. Promoting effect of antioxidants on two-stage urinary bladder carcinogenesis in rats. Toxicol. Lett. 31(Suppl.):199.
60. Lehman, A. J., O. G. Fitzhugh, A. A. Nelson, and G. Woodard. 1951. The pharmacological evaluation of antioxidants. Adv. Food Res. 3:197-208.
61. Leonard, C. D. 1977. Use of sodium erythorbate sprays for control of young tree decline in citrus. Proc. Fla. State Hortic. Soc. 89:29-31.
62. Leung, P. Y., K. Miyashita, M. Young, and C. S. Tsao. 1993. Cytotoxic effect of ascorbate and its derivatives on cultured malignant and nonmalignant cell lines. Anticancer Res. 13:475-480.
63. Lewis, R. J., Sr., ed. 1993. Hawley's condensed chemical dictionary. 12th ed., 99, 471. New York: Van Nostrand Reinhold.
64. Litton Bionetics, Inc. 1974. Mutagenic evaluation of compound FDA 71-66, Erythorbic Acid. Prepared for the FDA. NTIS No. PB-245 437.
65. Lohmann, W., D. Pagel, and V. Penka. 1984. Structure of ascorbic acid and its biological function. Determination of the conformation of ascorbic acid and isoascorbic acid by infrared and ultraviolet investigations. Eur. J. Biochem. 138:479-480.
66. Matsuoka, A., M. Hayashi, and M. Ishidate, Jr. 1979. Chromosomal aberration tests on 29 chemicals combined with S9 mix in vitro. Mutat. Res. 66:277-290.
67. Mitra, A., S. Govindwar, P. Joseph, and A. Kulkarni. 1992. Inhibition of human term placental and fetal liver glutathione-S-transferases by fatty acids and fatty acid esters. Toxicol. Lett. 60:281-288.
68. Mitra, A., V. C. Ravikumar, W. M. Bourn, and D. R. Bourcier. 1988. Influence of ascorbic acid esters on acetaminophen-induced hepatotoxicity in mice. Toxicol. Lett. 44:39-46.
69. Miyata, Y., S. Fukushima, M. Hirose, T. Masui, and N. Ito. 1985. Short-term screening of promoters of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl) nitrosamine-initiated, unilaterally ureter-ligated rats. Jpn. J. Cancer Res. 76:828-834.
70. Murata, A., M. Kawasaki, H. Motomatsu, and F. Kato. 1986. Virus-inactivating effect of D-isoascorbic acid. J. Nutr. Sci. Vitaminol. 32:559-567.
71. National Academy of Sciences. 1996. Food chemicals codex. 4th ed., 34, 134, 362. Washington, DC: National Academy Press.
72. National Formulary (NF). 1995. 18th ed. Rockville, MD: US Pharmacopeial Convention, Inc. p. 2215.
73. Newell, G. W., T. A. Jorgenson, and V. F. Simmon. 1974. Study of mutagenic effects of sodium erythorbate (FDA No. 71-68). Compound Report No. 4. Prepared under contract no. FDA 73-215. Washington, DC: FDA. (127pages.)
74. Nikitakis, J. M., G. N. McEwen, Jr., eds. 1990. CTFA compendium of cosmetic ingredient composition - specifications. Washington, DC: CTFA.
75. Nonaka, M. 1989. DNA repair tests on food additives. Environ. Mol. Mutagen. 14(Suppl. 15):143.
76. Oikarinen, A. 1992. Dermal connective tissue modulated by pharmacologic agents. Int. J. Dermatol. 31:149-156.
77. Omura, H., S. Iiyama, Y. Tomita, Y. Narazaki, K. Shinohara, and H. Murakami. 1975. Breaking action of ascorbic acid on nucleic acids. J. Nutr. Sci. Vitaminol. 21:237-249.
78. Omura, H., Y. Tomita, Y. Nakamura, and H. Murakami. 1974. Antitumoric potentiality of some ascorbate derivatives. J. Fac. Agr 18:181-189.
79. Orahovats, P. D. 1957. Toxicity studies with D-isoascorbic acid. FPC No. 0078. Rahway, NJ: Merck Institute of Therapeutic Research.
80. Pelletier, O. 1969. Turnover rates of D-isoascorbic acid and L-ascorbic acid in guinea pig organs. Can. J. Physiol. Pharmacol. 47:993-997.
81. Polec, R. B., S. D. J. Yeh, and M. E. Shils. 1971. Protective effect of ascorbic acid, isoascorbic acid and mannitol against tetracycline-induced nephrotoxicity. J. Pharm. Exp. Ther. 178:152-158.
82. Prival, M. J., V. F. Simmon, and K. E. Mortelmans. 1991. Bacterial mutagenicity testing of 49 food ingredients gives very few positive results. Mutat. Res. 260:321-329.
83. Radian Corporation. 1991. NTP chemical repository database. Bethesda, MD: National Library of Medicine.
84. Registry of Toxic Effects of Chemical Substances (RTECS). 1994. RTECS database. Bethesda, MD: National Library of Medicine.
85. Rempe, J. M., and L. G. Santucci, eds. 1992. CTFA list of Japanese cosmetic ingredients. 2nd ed., 5, 20. Washington, DC: CTFA.
86. Rothschild, D. L., Jr. 1990. The Food Chemical News guide to the current status of food additives and color additives, 461.1. Washington, DC: Louis Rothschild.
87. Sadoogh-Abasian, F., and D. F. Evered. 1979. Absorption of vitamin C from the human buccal cavity. Br. J. Nutr. 42:15-20.
88. Sax, N. I. 1979. Dangerous properties of industrial materials. 5th ed., 391. New York: Van Nostrand Reinhold.
89. Scientific Committee on Cosmetology (SCC). 1993. Opinion of the SCC (11/86-10/90). Brussels: Commission of the European Communities, p. 1-18.
90. Shibata, M. A., Y. Kurata, T. Ogiso, T. Masuo, and S. Fukushima. 1985. Response of urinary constituents and bladder epithelium to administration of chemicals and their sodium salts possessing promoting potential sodium salts. J. Toxicol. Soc. 10:264.
91. Shimizu, Y., D. S. McCann, and M. K. Keech. 1965a. The effect of ascorbic acid on human dermal fibroblasts in monolayer tissue culture. J. Lab. Clin. Med. 65:286-306.
92. Shimizu, Y., D. S. McCann, and M. K. Keech. 1965b. Human dermal fibroblasts in monolayer tissue culture. Effect of ascorbic acid analogues. J. Lab. Clin. Med. 66:659-666.
93. Shirai, T., A. Masuda, D. Fukushima, K. Hosoda, and N. Ito. 1985. Effects of sodium L-ascorbate and related compounds on rat stomach carcinogenesis initiated by N-methyl-N′-nitro-N-nitrosguanidine. Cancer Lett. 29:283-288.
94. Silber, R. H. 1956. Comparison of metabolism of ascorbic acid and isoascorbic acid. FPC No. 0317. Rahway, NJ: Merck Institute of Therapeutic Research. (2 pages.)
95. +-dependent, electroneutral L-ascorbate transport across brush border membrane vesicles from guinea pig small intestine. Biochim. Biophys. Acta 552:129-142.
96. Smart, R. C., M. T. Huang, Z. T. Han, M. C. Kaplan, A. Focella, and A. H. Conney. 1987. Inhibition of 12-o-tetradecanoylphorbol-13-acetate induction of ornithine decarboxylase activity, DNA synthesis, and tumor promotion in mouse skin by ascorbic acid and ascorbyl palmitate. Cancer Res. 47:6633-6638.
97. Suzuki, E., T. Kurata, and N. Arakawa. 1991. Comparison of absorption of erythorbic acid and ascorbic acid in the guinea pig small intestine. J. Nutr. Sci. Vitaminol. 37:453-459.
98. Suzuki, E., T. Kurata, M. Koda, and N. Arakawa. 1987. Erythorbic acid content in tissues of guinea pigs administered erythorbic acid. J. Nutr. Sci. Vitaminol. (Tokyo) 33:169-175.
99. Suzuki, E., T. Kurata, N. Sanceda, and N. Arakawa. 1986. Effect of graded doses of erythorbic acid on the ascorbic acid content of tissues of guinea pigs. J. Nutr. Sci. Vitaminol. (Tokyo) 32:335-342.
100. Teruuchi, J., and M. Okamura. 1972. Studies on vitamin C metabolism. Uptake of ascorbic acid and isoascorbic acid by human erythrocytes. Vitamins. 45:201-208.
101. +-dependent, electroneutral L-ascorbate transport across brush border membrane vesicles from human small intestine. FEBS Lett. 108:473-476.
102. Tsao, C. S., W. B. Dunham, and P. Y. Leung. 1992. Effect of ascorbic acid and its derivatives on the growth of human mammary tumor xenografts in mice. Cancer J. 5:53-59.
103. Tsao, C. S., and S. L. Salimi. 1983. Influence of erythorbic acid on ascorbic acid retention and elimination in the mouse. Int. J. Vitam. Nutr. Res. 53:258-264.
104. Wang, M. M., K. H. Fisher, and M. L. Dodds. 1962. Comparitive metabolic response to erythorbic acid and ascorbic acid by the human. J. Nutr. 77:443-447.
105. Wenninger, J. A., and G. N. McEwen, Jr., eds. 1997. International cosmetic ingredient dictionary and handbook. 7th ed., Vol. 1 and 2, 92, 93, 502, 1274. Washington, DC: CTFA.
106. WHO. 1974. Antioxidants, isoascorbic acid, and its sodium salt. Toxicological evaluation of some food additives including anticaking agents, antimicrobials, antioxidants, emulsifiers, and thickening agents. W1 W14H No. 5, 193-194. Geneva: WHO.
107. Yakuji Nippo, Ltd. 1979. The Japanese Standards of Cosmetic Ingredients. 1st ed., 31-32, 106. Tokyo, Japan: Yakuji Nippo, Ltd.
108. Yamazaki, H., T. Yamaguchi, A. Yamaguchi, and Y. Kakiuchi. 1993. Effect of food additives (antioxidants) on rabbit platelet functions. Japn. J. Toxicol. Environ. Health 39:453-458.
109. Zeiger, E. 1993. Mutagenicity of chemicals added to foods. Mutat. Res. 209: 53-61.